Literature DB >> 18830569

Role of immunoexpression of nitric oxide synthases by Hodgkin and Reed-Sternberg cells on apoptosis deregulation and on clinical outcome of classical Hodgkin lymphoma.

Antônio H J F M Campos1, Vera L Aldred, Karina C B Ribeiro, José Vassallo, Fernando A Soares.   

Abstract

Hodgkin and Reed-Sternberg (H-RS) cells of classical Hodgkin lymphoma (cHL) present an impaired expression of immunoglobulin genes, but escape apoptotic death. We investigated whether nitric oxide synthases (NOS) are expressed by H-RS cells, studied their association with EBV status and the expression of apoptotic proteins, and investigated their relationship to the clinical outcome of 171 patients. NOS1 and NOS2 were expressed in a large number of cases, whereas NOS3 expression was not detected. Positive associations were found between NOS1 and p53, bax and NOS2, bcl-2 and NOS2, bax and p53, and between bax and fasL. Inverse correlations were established between EBV and NOS2 and between EBV and bcl-2. A shorter overall survival (OS) was associated with strong expression of NOS2. In conclusion, NOS are expressed by H-RS cells of cHL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18830569     DOI: 10.1007/s11010-008-9923-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  41 in total

1.  Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression.

Authors:  Alexey Ushmorov; Olga Ritz; Michael Hummel; Frank Leithäuser; Peter Möller; Harald Stein; Thomas Wirth
Journal:  Blood       Date:  2004-07-29       Impact factor: 22.113

Review 2.  Nitric oxide synthases: roles, tolls, and controls.

Authors:  C Nathan; Q W Xie
Journal:  Cell       Date:  1994-09-23       Impact factor: 41.582

Review 3.  The proto-oncogene Bcl-2 and its role in regulating apoptosis.

Authors:  G Kroemer
Journal:  Nat Med       Date:  1997-06       Impact factor: 53.440

4.  Expression of nitric oxide synthase isoforms and nitrotyrosine immunoreactivity by B-cell non-Hodgkin's lymphomas and multiple myeloma.

Authors:  R V Mendes; A R Martins; G de Nucci; F Murad; F A Soares
Journal:  Histopathology       Date:  2001-08       Impact factor: 5.087

Review 5.  Biosynthesis and action of nitric oxide in mammalian cells.

Authors:  B Mayer; B Hemmens
Journal:  Trends Biochem Sci       Date:  1997-12       Impact factor: 13.807

Review 6.  Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide.

Authors:  D A Wink; J B Mitchell
Journal:  Free Radic Biol Med       Date:  1998-09       Impact factor: 7.376

7.  Expression of bcl-2 protein and transcription of the Epstein-Barr virus bcl-2 homologue BHRF-1 in Hodgkin's disease: implications for different pathogenic mechanisms.

Authors:  N M Jiwa; J J Oudejans; M C Bai; A J Van den Brule; A Horstman; W Vos; P Van der Valk; P M Kluin; J M Walboomers; C J Meijer
Journal:  Histopathology       Date:  1995-06       Impact factor: 5.087

8.  Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays.

Authors:  Juan F García; Francisca I Camacho; Manuel Morente; Máximo Fraga; Carlos Montalbán; Tomás Alvaro; Carmen Bellas; Angel Castaño; Ana Díez; Teresa Flores; Carmen Martin; Miguel A Martinez; Francisco Mazorra; Javier Menárguez; Maria J Mestre; Manuela Mollejo; Ana I Sáez; Lydia Sánchez; Miguel A Piris
Journal:  Blood       Date:  2002-09-12       Impact factor: 22.113

Review 9.  The role of nitric oxide in cancer.

Authors:  Weiming Xu; Li Zhi Liu; Marilena Loizidou; Mohamed Ahmed; Ian G Charles
Journal:  Cell Res       Date:  2002-12       Impact factor: 25.617

10.  Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation.

Authors:  J B Mannick; K Asano; K Izumi; E Kieff; J S Stamler
Journal:  Cell       Date:  1994-12-30       Impact factor: 41.582

View more
  10 in total

1.  Increased expression of CD4+CD25 +FOXP3+ regulatory T cells correlates with Epstein-Barr virus and has no impact on survival in patients with classical Hodgkin lymphoma in Brazil.

Authors:  Mariane C G Assis; Antonio H F M Campos; Jose S R Oliveira; Fernando A Soares; Joyce M K Silva; Priscilla B Silva; Adriana D Penna; Eni M Souza; Otavio C G Baiocchi
Journal:  Med Oncol       Date:  2012-07-13       Impact factor: 3.064

2.  Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.

Authors:  Russell J H Ryan; Yotam Drier; Holly Whitton; M Joel Cotton; Jasleen Kaur; Robbyn Issner; Shawn Gillespie; Charles B Epstein; Valentina Nardi; Aliyah R Sohani; Ephraim P Hochberg; Bradley E Bernstein
Journal:  Cancer Discov       Date:  2015-07-30       Impact factor: 39.397

3.  HIF1-alpha expression predicts survival of patients with squamous cell carcinoma of the oral cavity.

Authors:  Marcelo dos Santos; Ana Maria da Cunha Mercante; Iúri Drumond Louro; Antônio José Gonçalves; Marcos Brasilino de Carvalho; Eloiza Helena Tajara da Silva; Adriana Madeira Álvares da Silva
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

4.  An overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients.

Authors:  Riguel J Inaoka; Achim A Jungbluth; Otávio Cg Baiocchi; Mariane Cg Assis; Nicole C Hanson; Denise Frosina; Jodie Tassello; Adriana B Bortoluzzo; Antonio C Alves; Gisele Wb Colleoni
Journal:  BMC Cancer       Date:  2011-09-28       Impact factor: 4.430

5.  HIF-1alpha expression profile in intratumoral and peritumoral inflammatory cells as a prognostic marker for squamous cell carcinoma of the oral cavity.

Authors:  Suzanny Oliveira Mendes; Marcelo dos Santos; Gabriela Tonini Peterle; Lucas de Lima Maia; Elaine Stur; Lidiane Pignaton Agostini; Marcos Brasilino de Carvalho; Eloiza Helena Tajara; Iúri Drumond Louro; Leonardo Oliveira Trivilin; Adriana Madeira Álvares da Silva-Conforti
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

6.  FGFR4 profile as a prognostic marker in squamous cell carcinoma of the mouth and oropharynx.

Authors:  Roberta Lelis Dutra; Marcos Brasilino de Carvalho; Marcelo Dos Santos; Ana Maria da Cunha Mercante; Diana Gazito; Rafael de Cicco; Gencapo Group; Eloiza Helena Tajara; Iúri Drumond Louro; Adriana Madeira Álvares da Silva
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

7.  Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation.

Authors:  Lisa A Ridnour; Kimberly M Barasch; Alisha N Windhausen; Tiffany H Dorsey; Michael M Lizardo; Harris G Yfantis; Dong H Lee; Christopher H Switzer; Robert Y S Cheng; Julie L Heinecke; Ernst Brueggemann; Harry B Hines; Chand Khanna; Sharon A Glynn; Stefan Ambs; David A Wink
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

8.  Matrix metalloproteinase-9 expression by Hodgkin-Reed-Sternberg cells is associated with reduced overall survival in young adult patients with classical Hodgkin lymphoma.

Authors:  Antonio Hugo Campos; Jose Vassallo; Fernando Augusto Soares
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

9.  FAS/FASL expression profile as a prognostic marker in squamous cell carcinoma of the oral cavity.

Authors:  Paulo Bentes de Carvalho-Neto; Marcelo dos Santos; Marcos Brasilino de Carvalho; Ana Maria da Cunha Mercante; Viviane Priscila Pina dos Santos; Patrícia Severino; Eloiza Helena Tajara; Iuri Drumond Louro; Adriana Madeira Álvares da Silva-Conforti
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

10.  Frequency of EBV associated classical Hodgkin lymphoma decreases over a 54-year period in a Brazilian population.

Authors:  Antonio Hugo Jose Froes Marques Campos; Adriana Moreira; Karina Braga Ribeiro; Roberto Pinto Paes; Maria Claudia Zerbini; Vera Aldred; Carmino Antonio de Souza; Cristovam Scapulatempo Neto; Fernando Augusto Soares; Jose Vassallo
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.